tiprankstipranks
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market
Holding ALLO?
Track your performance easily

Allogene Therapeutics (ALLO) Cash flow

1,324 Followers

Allogene Therapeutics Cash Flow

ALLO's free cash flow for Q3 2024 was $-44.54M. For the 2024 fiscal year, ALLO's free cash flow was decreased by $-13.54M and operating cash flow was $-44.12M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -217.31M$ -237.73M$ -220.52M$ -184.81M$ -115.09M$ -137.35M
Investing Cash Flow
$ 88.22M$ 163.29M$ 106.16M$ 163.66M$ -505.12M$ 164.08M
Financing Cash Flow
$ 111.09M$ 95.69M$ 2.95M$ 11.96M$ 633.59M$ 58.96M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 309.76M$ 93.45M$ 72.20M$ 183.61M$ 192.80M$ 179.43M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 1.53M$ 93.61M$ 2.46M$ 3.62M$ 598.57M$ 56.00M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -217.93M$ -239.25M$ -225.71M$ -206.26M$ -181.05M$ -188.14M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Allogene Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis